PubRank

Stefan Seregard

Author PubWeight™ 58.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Uveal melanoma: epidemiologic aspects. Ophthalmol Clin North Am 2005 2.24
2 Choroidal biopsies for intraocular tumors of indeterminate origin. Am J Ophthalmol 2005 1.87
3 Photochemical damage of the retina. Surv Ophthalmol 2006 1.83
4 Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study. Ophthalmology 2012 1.78
5 Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study. Arch Ophthalmol 2011 1.78
6 Ligneous conjunctivitis. Surv Ophthalmol 2003 1.59
7 Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmol Scand 2006 1.47
8 Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target. Invest Ophthalmol Vis Sci 2002 1.33
9 Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population. Ophthalmology 2005 1.32
10 Sunlight exposure and pathogenesis of uveal melanoma. Surv Ophthalmol 2004 1.20
11 Molecular and clinical spectrum of type I plasminogen deficiency: A series of 50 patients. Blood 2006 1.20
12 Bevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical study. Ophthalmology 2012 1.15
13 Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice. Invest Ophthalmol Vis Sci 2003 1.14
14 The cut-and-paste method for primary pterygium surgery: long-term follow-up. Acta Ophthalmol Scand 2005 1.12
15 The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells. Clin Cancer Res 2006 1.09
16 Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation. Cell Mol Life Sci 2013 1.08
17 Incidence of uveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci 2002 1.08
18 Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor. Invest Ophthalmol Vis Sci 2008 0.99
19 Intratumoral forkhead box P3-positive regulatory T cells predict poor survival in cyclooxygenase-2-positive uveal melanoma. Cancer 2010 0.98
20 A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations. Acta Ophthalmol 2007 0.96
21 Expression and prognostic significance of iNOS in uveal melanoma. Int J Cancer 2010 0.96
22 Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice. Exp Eye Res 2005 0.95
23 c-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target? Invest Ophthalmol Vis Sci 2004 0.95
24 Selective recruitment of G protein-coupled receptor kinases (GRKs) controls signaling of the insulin-like growth factor 1 receptor. Proc Natl Acad Sci U S A 2012 0.94
25 Age-related maculopathy: pathogenetic features and new treatment modalities. Acta Ophthalmol Scand 2002 0.93
26 Uveal melanoma: a study on incidence of additional cancers in the Swedish population. Invest Ophthalmol Vis Sci 2006 0.92
27 Oncocytoma of the lacrimal gland. Acta Ophthalmol Scand 2007 0.91
28 Intraoperative mitomycin C versus autologous conjunctival autograft in surgery of primary pterygium with four-year follow-up. Acta Ophthalmol 2010 0.91
29 To biopsy or not to biopsy? Acta Ophthalmol 2009 0.90
30 Structure and function of the N-cadherin/catenin complex in retinoblastoma. Invest Ophthalmol Vis Sci 2002 0.89
31 Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications. Invest Ophthalmol Vis Sci 2005 0.89
32 Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma. Invest Ophthalmol Vis Sci 2008 0.89
33 Subthreshold transpupillary thermotherapy reduces experimental choroidal neovascularization in the mouse without collateral damage to the neural retina. Invest Ophthalmol Vis Sci 2004 0.88
34 Fine-needle aspiration cytology and immunocytochemistry of orbital masses. Diagn Cytopathol 2006 0.88
35 A prospective study of children treated for retinoblastoma: cognitive and visual outcomes in relation to treatment. Acta Ophthalmol Scand 2002 0.88
36 Topical chemotherapy for ocular surface squamous neoplasia: current status. Br J Ophthalmol 2009 0.87
37 Uveal melanoma survival in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci 2003 0.86
38 Mantle cell lymphoma of the iris. Acta Ophthalmol Scand 2007 0.86
39 Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications. Acta Ophthalmol 2008 0.85
40 Photodynamic therapy for circumscribed choroidal haemangioma. Acta Ophthalmol Scand 2002 0.83
41 Transpupillary thermotherapy of predominantly occult choroidal neovascularization in age-related macular degeneration with 12 months follow-up. Acta Ophthalmol Scand 2003 0.83
42 JARID1B protein expression and prognostic implications in uveal melanoma. Invest Ophthalmol Vis Sci 2012 0.82
43 Nuclear HER3 is associated with favorable overall survival in uveal melanoma. Int J Cancer 2011 0.82
44 Malignant solitary fibrous tumour of the orbit. Acta Ophthalmol 2008 0.80
45 Retinoblastoma: direct chemotherapeutic drug delivery into the vitreous cavity. Br J Ophthalmol 2012 0.80
46 Combination therapy with low-dose transpupillary thermotherapy and intravitreal ranibizumab for neovascular age-related macular degeneration: a 24-month prospective randomised clinical study. Br J Ophthalmol 2012 0.79
47 Vision-related function after low-dose transpupillary thermotherapy versus photodynamic therapy for neovascular age-related macular degeneration. Acta Ophthalmol 2010 0.79
48 Retinal vascular development and pathologic retinal angiogenesis are not impaired in matrix metalloproteinase-2 deficient mice. Curr Eye Res 2005 0.79
49 The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells. Acta Ophthalmol 2008 0.79
50 Photoreceptor survival in transplantation of autologous iris pigment epithelial cells to the subretinal space. Acta Ophthalmol Scand 2002 0.79
51 Carcinoid presenting as extrinsic eye muscle metastasis. Acta Ophthalmol 2009 0.78
52 Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor. Acta Ophthalmol 2008 0.78
53 Visual improvement in central retinal vein occlusion (CRVO) following intravitreal injections of bevacizumab (Avastin(®) ). Acta Ophthalmol 2010 0.78
54 TIMP-3 mRNA is not overexpressed in Sorsby fundus dystrophy. Am J Ophthalmol 2003 0.78
55 Intravitreal bevacizumab in central retinal vein occlusion: 18-month results of a prospective clinical trial. Eur J Ophthalmol 2011 0.77
56 Uveitis masquerade syndromes: diffuse retinoblastoma in an older child. Acta Ophthalmol Scand 2007 0.77
57 Primary transpupillary thermotherapy of "small" choroidal melanoma: is it safe? Br J Ophthalmol 2008 0.77
58 Safety of irrigation with 5-fluorouracil in a sealed-capsule irrigation device in the rabbit eye. J Cataract Refract Surg 2007 0.77
59 Drusen maculopathy: a risk factor for AMD. Can we prevent visual loss? Acta Ophthalmol Scand 2003 0.76
60 Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma. Acta Ophthalmol 2008 0.76
61 Who's the faster runner: the cheetah or the rabbit? Acta Ophthalmol 2009 0.75
62 Shall we use Avastin or Lucentis for ocular neovascularization? Acta Ophthalmol 2008 0.75
63 Preoperative sub-Tenon's capsule injection of ropivacaine in conjunction with general anesthesia in retinal detachment surgery. Ophthalmology 2007 0.75
64 Nordic research in ophthalmology. Acta Ophthalmol Scand 2005 0.75
65 Dystrophia Smolandiensis: a novel morphological picture of recurrent corneal erosions. Acta Ophthalmol 2009 0.75
66 Swedish ophthalmology faces up to the 21st century. Acta Ophthalmol 2008 0.75
67 Angle involvement and glaucoma in patients with biopsy-proven iris melanoma: a response-reply. Arch Ophthalmol 2012 0.75
68 EJO talks to Stefan Seregard, President of the European Society of Ophthalmology, about the SOE 2015 congress and what makes the SOE congress so unique. Eur J Ophthalmol 2015 0.75
69 Characterization of plasminogen variants in healthy subjects and plasminogen mutants in patients with inherited plasminogen deficiency by isoelectric focusing gel electrophoresis. Thromb Haemost 2004 0.75
70 Malignant melanoma of soft parts arising from Tenon's capsule. Acta Ophthalmol 2009 0.75
71 Gullstrand's Nobel Prize. 100 years and counting. Acta Ophthalmol 2011 0.75
72 Detection of diabetic retinopathy: a comparison between red-free digital images and colour transparencies. Graefes Arch Clin Exp Ophthalmol 2004 0.75